Episurf Logo

Episurf

ISIN: SE0003491562 | Ticker: EPIS | LEI: 549300GORBCSMHZB2J75
Sector: Health CareSub-Industry: Health Care Technology
Country: Sweden

About Episurf

Company Description

Episurf Medical is endeavouring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer personalised endoprostheses and Epiguide surgical drill guides are used for treating localised cartilage injury in joints following precise 3D modelling. Episurf Medical’s μiFidelity system will enable endoprostheses to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention.

Headquarters

Karlavägen 60, 11449 Stockholm – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 185,400,000.00 270,600,000.00 197,200,000.00
Noncurrent Assets N/A 25,100,000.00 26,300,000.00 36,200,000.00
Office Equipment N/A 0.00 100,000.00 N/A
Intangible Assets Other Than Goodwill N/A 20,800,000.00 23,000,000.00 29,500,000.00
Intangible Assets Under Development N/A 6,700,000.00 9,000,000.00 N/A
Other Noncurrent Receivables N/A 500,000.00 0.00 N/A
Current Assets N/A 160,300,000.00 244,400,000.00 161,000,000.00
Inventories N/A 2,000,000.00 1,900,000.00 1,900,000.00
Current Trade Receivables N/A 600,000.00 1,600,000.00 1,900,000.00
Other Current Receivables N/A 900,000.00 1,600,000.00 900,000.00
Cash and cash equivalents 25,300,000.00 155,000,000.00 237,900,000.00 155,300,000.00
Equity And Liabilities N/A 185,400,000.00 270,600,000.00 197,200,000.00
Equity 41,400,000.00 169,500,000.00 252,800,000.00 177,700,000.00
Issued Capital N/A 66,700,000.00 80,000,000.00 80,100,000.00
Retained Earnings N/A -443,200,000.00 -511,300,000.00 -587,000,000.00
Other Reserves N/A -200,000.00 -300,000.00 -200,000.00
Additional Paidin Capital N/A 546,200,000.00 684,400,000.00 684,800,000.00
Liabilities N/A 16,000,000.00 17,800,000.00 19,500,000.00
Noncurrent Liabilities N/A 2,100,000.00 3,500,000.00 4,800,000.00
Other Noncurrent Liabilities N/A 600,000.00 2,800,000.00 1,000,000.00
Current Liabilities N/A 13,900,000.00 14,200,000.00 14,700,000.00
Trade And Other Current Payables To Trade Suppliers N/A 5,400,000.00 5,900,000.00 4,400,000.00
Current Accruals And Current Deferred Income Including Current Contract Liabilities N/A N/A 4,900,000.00 6,000,000.00
Other Current Liabilities N/A 2,300,000.00 1,400,000.00 1,800,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 5,000,000.00 6,500,000.00 6,600,000.00
Other Income 2,000,000.00 400,000.00 300,000.00
Other Work Performed By Entity And Capitalised 4,100,000.00 6,900,000.00 11,300,000.00
Cost Of Merchandise Sold 5,100,000.00 4,800,000.00 4,200,000.00
Employee Benefits Expense 28,300,000.00 33,900,000.00 40,300,000.00
Depreciation And Amortisation Expense 7,600,000.00 7,400,000.00 7,400,000.00
Other Expense By Nature 33,500,000.00 37,100,000.00 43,300,000.00
Profit Loss From Operating Activities -63,400,000.00 -69,400,000.00 -77,000,000.00
Finance Income 100,000.00 400,000.00 500,000.00
Finance Costs 700,000.00 200,000.00 700,000.00
Profit Loss Before Tax -63,900,000.00 -69,200,000.00 -77,200,000.00
Income Tax Expense Continuing Operations 0.00 0.00 100,000.00
Profit (loss) -63,900,000.00 -69,300,000.00 -77,300,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -63,900,000.00 -69,300,000.00 -77,300,000.00
Adjustments For Decrease Increase In Inventories N/A -200,000.00 0.00 100,000.00
Adjustments For Decrease Increase In Other Operating Receivables N/A -800,000.00 -600,000.00 1,500,000.00
Adjustments For Increase Decrease In Other Operating Payables N/A 1,000,000.00 800,000.00 -400,000.00
Adjustments For Depreciation And Amortisation Expense N/A 7,600,000.00 7,400,000.00 7,400,000.00
Adjustments For Sharebased Payments N/A 1,400,000.00 3,300,000.00 -200,000.00
Interest Paid Classified As Operating Activities N/A 0.00 200,000.00 600,000.00
Interest Received Classified As Operating Activities N/A 0.00 100,000.00 100,000.00
Cash Flows From Used In Operating Activities N/A -54,100,000.00 -59,700,000.00 -69,500,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 0.00 100,000.00 0.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 4,600,000.00 6,900,000.00 11,300,000.00
Cash Flows From Used In Investing Activities N/A -5,100,000.00 -6,500,000.00 -11,200,000.00
Proceeds From Issuing Shares N/A 190,900,000.00 150,600,000.00 0.00
Proceeds From Issuing Other Equity Instruments N/A 100,000.00 900,000.00 0.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 2,200,000.00 2,400,000.00 2,400,000.00
Cash Flows From Used In Financing Activities N/A 188,800,000.00 149,200,000.00 -1,900,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 129,700,000.00 83,000,000.00 -82,600,000.00
Cash and cash equivalents 25,300,000.00 155,000,000.00 237,900,000.00 155,300,000.00

Please note that some sums might not add up.

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
10.05.23 Laura Shunk Other Buy USD 7,800.00
08.05.23 Pål Ryfors Other Buy SEK 203,180.06
05.05.23 Pål Ryfors Other Buy SEK 81,155.00
05.05.23 Pål Ryfors Other Buy SEK 79,685.00
05.05.23 Pål Ryfors Other Buy SEK 79,000.00
05.05.23 Pål Ryfors Other Buy SEK 78,400.00
05.05.23 Pål Ryfors Other Buy SEK 78,270.00
05.05.23 Pål Ryfors Other Buy SEK 61,368.42
22.02.23 Leif Ryd Other Buy SEK 108,500.00
22.02.23 Leif Ryd Other Buy SEK 54,250.00

Capital markets information

ISIN

SE0003491562

LEI

549300GORBCSMHZB2J75

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Technology

Sub-Industry

Health Care Technology

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.